title: From the editor: an interview with Dr. Scott Grundy.
abstract: During the American Heart Association's Scientific Sessions in November 2014, this Editor had the opportunity to interview Dr. Scott Grundy regarding the new recommendations for guideline development that was issued by the International Atherosclerosis Society. (The full document is published in this issue of the journal). In developing this report, Dr. Grundy chaired a panel of international experts who spent 1 year in consideration of new evidence and regional concerns regarding the clinical management of lipoprotein disorders and vascular disease prevention. His experience in developing the Adult Treatment Panel Reports from the National Cholesterol Education Program in the United States and his extensive research in lipoprotein physiology and related disorders makes him unique in offering the expertise for worldwide leadership in this effort.
authors: Emory University School of Medicine, 3208 Habersham Road NW, Atlanta, GA 30305, USA. Electronic address: wbrow925@bellsouth.net.
authors: Scott
authors: S
authors: Grundy
authors: Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Suite Y3.206, Dallas, TX, USA.
authors: W Virgil
authors: WV
authors: Brown
mesh_terms: D026683:Advisory Committees; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D002986:Clinical Trials as Topic; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D006801:Humans; D017410:Practice Guidelines as Topic; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D014280:Triglycerides
keywords: Dyslipidemia; Guidelines; HDL; LDL; Lipoproteins